Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Stealth and cunning: hepatitis B and hepatitis C viruses.

Literature DB >> 16014900

Stealth and cunning: hepatitis B and hepatitis C viruses.

Stefan F Wieland¹, Francis V Chisari.

Abstract

Entities: Disease

Mesh：

Year: 2005 PMID： 16014900 PMCID： PMC1181548 DOI： 10.1128/JVI.79.15.9369-9380.2005

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

× No keyword cloud information.

180 in total

1. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

Authors: K Moriya; H Yotsuyanagi; Y Shintani; H Fujie; K Ishibashi; Y Matsuura; T Miyamura; K Koike
Journal: J Gen Virol Date: 1997-07 Impact factor: 3.891

2. Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice.

Authors: A Franco; L G Guidotti; M V Hobbs; V Pasquetto; F V Chisari
Journal: J Immunol Date: 1997-08-15 Impact factor: 5.422

3. Hepatitis C virus core and E2 protein expression in transgenic mice.

Authors: C Pasquinelli; J M Shoenberger; J Chung; K M Chang; L G Guidotti; M Selby; K Berger; R Lesniewski; M Houghton; F V Chisari
Journal: Hepatology Date: 1997-03 Impact factor: 17.425

4. Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission.

Authors: W F Carman; W Boner; G Fattovich; K Colman; E S Dornan; M Thursz; S Hadziyannis
Journal: J Infect Dis Date: 1997-05 Impact factor: 5.226

Review 5. Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection.

Authors: A J Weiner; A L Erickson; J Kansopon; K Crawford; E Muchmore; M Houghton; C M Walker
Journal: Princess Takamatsu Symp Date: 1995

6. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

Authors: K M Chang; B Rehermann; J G McHutchison; C Pasquinelli; S Southwood; A Sette; F V Chisari
Journal: J Clin Invest Date: 1997-11-01 Impact factor: 14.808

7. Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope.

Authors: T Kaneko; T Moriyama; K Udaka; K Hiroishi; H Kita; H Okamoto; H Yagita; K Okumura; M Imawari
Journal: Eur J Immunol Date: 1997-07 Impact factor: 5.532

8. Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes.

Authors: K Koike; K Moriya; K Ishibashi; H Yotsuyanagi; Y Shintani; H Fujie; K Kurokawa; Y Matsuura; T Miyamura
Journal: Proc Natl Acad Sci U S A Date: 1997-01-07 Impact factor: 11.205

9. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

Authors: B Rehermann; C Ferrari; C Pasquinelli; F V Chisari
Journal: Nat Med Date: 1996-10 Impact factor: 53.440

10. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.

Authors: M J Gale; M J Korth; N M Tang; S L Tan; D A Hopkins; T E Dever; S J Polyak; D R Gretch; M G Katze
Journal: Virology Date: 1997-04-14 Impact factor: 3.616

168 in total

10. Testing the balanced electrostatic interaction hypothesis of hepatitis B virus DNA synthesis by using an in vivo charge rebalance approach.

Authors: Pong Kian Chua; Fan-Mei Tang; Jyuan-Yuan Huang; Ching-Shu Suen; Chiaho Shih
Journal: J Virol Date: 2009-12-16 Impact factor: 5.103

Stealth and cunning: hepatitis B and hepatitis C viruses.

1. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

2. Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice.

3. Hepatitis C virus core and E2 protein expression in transgenic mice.

4. Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission.

Review 5. Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection.

6. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

7. Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope.

8. Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes.

9. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

10. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.

1. DNA vaccine: a promising new approach for chronic hepatitis B therapy.

Review 2. Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus.

3. N ⁶-Methyladenosine modification of hepatitis B and C viral RNAs attenuates host innate immunity via RIG-I signaling.

4. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.

5. Compartmentalization of hepatitis B virus: Looking beyond the liver.

6. The induction of type I interferon production in hepatitis C-infected patients.

7. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus.

8. Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver.

9. Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus.

10. Testing the balanced electrostatic interaction hypothesis of hepatitis B virus DNA synthesis by using an in vivo charge rebalance approach.